Evidence map›Paper›PMID 41993748›Full record

ArticleFrontiers in plant science2026

Substrate-driven reprogramming of the rhizosphere metabolome underlies enhanced tomato growth and quality in soilless cultivation.

Yu Chen, Yuyuan Chai, Xi Chen, Jing Shi

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yu ChenCollege of Resources and Environment, Yunnan Agricultural University, Kunming, China.
Yuyuan ChaiCollege of Resources and Environment, Yunnan Agricultural University, Kunming, China.
Xi ChenKunming Changshui International Airport Power Energy Department, Kunming, China.
Jing ShiCollege of Resources and Environment, Yunnan Agricultural University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The rhizosphere metabolome is a crucial mediator of plant-substrate interactions, yet how different cultivation substrates reprogram this metabolic interface and influence crop performance remains poorly understood. Methods: Using tomato as a model, we employed non-targeted metabolomics based on solvent extraction followed by gas chromatography-mass spectrometry (GC-MS) to compare rhizosphere metabolic profiles under three substrates: conventional facility soil (SL), pinecone residue (PR), and peat substrate (PS). Results: We identified and annotated 276 metabolites, with lipids and lipid-like molecules being the most abundant class (24.28%). Substrate type fundamentally reshaped the metabolome, with PR inducing the most distinct profile and PS triggering the most extensive metabolic reprogramming (277 differential metabolites). Notably, over 91% of differential metabolites were up-regulated upon tomato cultivation. The superior physicochemical properties (e.g., lower bulk density, higher nutrient availability) of organic substrates (PR and PS) were linked to both the distinct metabolic signatures and significant enhancements in tomato growth and fruit quality, particularly in PS which showed an 80.08% yield increase and a 50.19% boost in fruit vitamin C content. Discussion: Our findings demonstrate that organic substrates, especially peat, enhance plant performance by activating a more diverse and functionally specialized rhizosphere metabolome, providing a mechanistic basis for optimizing substrate selection in facility agriculture.

Indexed as

culture mediummetabolomicspeat substratepinecone residue substraterhizosphere metabolites

Identifiers

PMID41993748
PMCPMC13079676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.